monoclonal antibodies

Parent Topic

pharmaceuticals

Information Sources addressing Topic

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Effective treatment of severe COVID-19 patients with tocilizumab
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
SARS-like WIV1-CoV poised for human emergence

Topic ID

1034